The John Hunter Hospital and John Hunter Children's Hospital is the principal referral centre and a tertiary hospital for Newcastle, and northern New South Wales, Australia. The 796 bed hospital is the main teaching hospital of the University of Newcastle.

There are 550 (796 inclusive of JHCH and Royal Newcastle Centre) beds in John Hunter Hospital.

During the past decade, John Hunter Hospital conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 21 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 13 clinical trials were completed. i.e. 31% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Hunter Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 8 trials, followed by "Neuroscience Trials Australia" with 7 trials sponsored, "The George Institute" with 6 trials sponsored, "University of Melbourne" with 6 trials sponsored and "Children's Oncology Group" with 6 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Hunter Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 14 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "The Florey Institute of Neuroscience and Mental Health" with 5 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 4 trials as a collaborator and "Medical Research Institute of New Zealand" with 4 trials as a collaborator. Other collaborators include 165 different institutions and companies that were collaborators in the rest 148 trials.

According to Clinical.Site data, the most researched conditions in "John Hunter Hospital" are "Heart Failure" (9 trials), "Stroke" (7 trials), "Cystic Fibrosis" (6 trials), "Ischemic Stroke" (6 trials) and "Atrial Fibrillation" (4 trials). Many other conditions were trialed in "John Hunter Hospital" in a lesser frequency.

Most popular intervention types in "John Hunter Hospital" are "Drug" (98 trials), "Other" (25 trials), "Procedure" (18 trials), "Device" (14 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Tenecteplase" (5 trials), "IVA" (4 trials), "Tranexamic Acid" (4 trials) and "Empagliflozin" (3 trials). Other intervention names were less common.

The vast majority of trials in "John Hunter Hospital" are 137 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are 55 active trials in "John Hunter Hospital". 2 are not yet recruiting, 33 are recruiting, 19 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 66 completed trials in John Hunter Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in John Hunter Hospital, 1 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 26 trials that are defined as “Not Applicable".